Joan Fusco, PhD

Chief Development Officer

Dr. Joan Fusco has thirty years’ experience in the biotechnology/vaccines industry serving across major functional areas with 20 of those years in executive management holding responsibility for technical, programmatic, and general operations. Her expertise is navigating the biopharmaceutical product development life cycle from concept to commercialization. Her various operational leadership positions have resulted in the successful commercialization of four new products with significant healthcare and revenue impact (2 US and 2 EU/Can/Global).

Dr. Fusco earned her Ph.D. in Microbiology (Biological Sciences; bacterial virulence/immunity factors) from the University of Pittsburgh. She has deep experience in the development of a multitude of vaccine products for existing and emerging infectious diseases and biothreats, including filoviruses, meningitis A/B/C, Hib, Group B strep, Group A strep, pseudomonas, gonorrhea, diphtheria, tetanus, pertussis, polio, pneumococcus, West Nile, Japanese encephalitis, smallpox, anthrax, plague, influenza (seasonal and pandemic), and Zika. She has presented at numerous conferences and served on Wellcome Trust’s Ebola Vaccine Team B.

More team members

Andrew Fradkin, JD
General Counsel
Walter Greenblatt, MBA
Chief Financial Officer
Mike McGinnis, MS, MBA
Head of Government Relations
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Chairwoman of the Board
Fred Hayden, MD
Tom Monath, MD
Chief Medical Officer
Sean Whelan, PhD
Allen Duplantier, PhD
Principal investigator
Daniel Graifman, MBA